{"entity":{"type":"insider","cik":"0001430370","url":"/insider/0001430370","json_url":"/insider/0001430370.json","name":"Goffe Andrew J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":20,"first":"2008-03-28","last":"2009-03-12","span_basis":"filed_date"},"name_variants":[{"name":"Goffe Andrew J.","source":"filing","n_filings":20,"first_seen":"2008-03-28","last_seen":"2009-03-12"}],"transactions":[{"id":5791839,"accession":"0000902664-09-001108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-001108","line_url":"/filing/0000902664-09-001108#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Goffe Andrew J.; Schafer Brother LLC","owner_display_name":"OSS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11324.0,"shares_display":"11,324","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":101916.0,"total_display":"101,916.00","total_whole":"101,916","shares_owned_after":2486444.0,"shares_owned_after_display":"2,486,444","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-10","filed_date":"2009-03-12","scope":"insider"},{"id":5686060,"accession":"0000902664-09-001099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-09-001099","line_url":"/filing/0000902664-09-001099","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Schafer Brother LLC; SCHAFER OSCAR; Goffe Andrew J.; OSS CAPITAL MANAGEMENT","owner_display_name":"Schafer Brother LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233100.0,"shares_display":"233,100","price_per_share":9.021510081510081,"price_display":"9.02","price_state":"stated","total_value":2102914.0,"total_display":"2,102,914.00","total_whole":"2,102,914","shares_owned_after":2498868.0,"shares_owned_after_display":"2,498,868","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-04","filed_date":"2009-03-06","scope":"insider","n_lines":2},{"id":5946250,"accession":"0000902664-09-001083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-001083","line_url":"/filing/0000902664-09-001083#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"SCHAFER OSCAR; Goffe Andrew J.; Schafer Brother LLC; OSS CAPITAL MANAGEMENT","owner_display_name":"SCHAFER OSCAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":529.0,"shares_display":"529","price_per_share":9.65,"price_display":"9.65","price_state":"stated","total_value":5104.85,"total_display":"5,104.85","total_whole":"5,105","shares_owned_after":2730868.0,"shares_owned_after_display":"2,730,868","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-02","filed_date":"2009-03-04","scope":"insider"},{"id":5621798,"accession":"0000902664-09-001048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-09-001048","line_url":"/filing/0000902664-09-001048#line-2","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Goffe Andrew J.; Schafer Brother LLC","owner_display_name":"OSS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5398.0,"shares_display":"5,398","price_per_share":9.65,"price_display":"9.65","price_state":"stated","total_value":52090.7,"total_display":"52,090.70","total_whole":"52,091","shares_owned_after":2731397.0,"shares_owned_after_display":"2,731,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-20","filed_date":"2009-02-23","scope":"insider"},{"id":5621797,"accession":"0000902664-09-001048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-001048","line_url":"/filing/0000902664-09-001048#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Goffe Andrew J.; Schafer Brother LLC","owner_display_name":"OSS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":9.65,"price_display":"9.65","price_state":"stated","total_value":67550.0,"total_display":"67,550.00","total_whole":"67,550","shares_owned_after":2736795.0,"shares_owned_after_display":"2,736,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-19","filed_date":"2009-02-23","scope":"insider"},{"id":5603710,"accession":"0000902664-09-001041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-09-001041","line_url":"/filing/0000902664-09-001041#line-2","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Schafer Brother LLC; Goffe Andrew J.; OSS CAPITAL MANAGEMENT; SCHAFER OSCAR","owner_display_name":"Schafer Brother LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":9.65,"price_display":"9.65","price_state":"stated","total_value":96500.0,"total_display":"96,500.00","total_whole":"96,500","shares_owned_after":2743795.0,"shares_owned_after_display":"2,743,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-18","filed_date":"2009-02-19","scope":"insider"},{"id":5603709,"accession":"0000902664-09-001041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-001041","line_url":"/filing/0000902664-09-001041#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Schafer Brother LLC; Goffe Andrew J.; OSS CAPITAL MANAGEMENT; SCHAFER OSCAR","owner_display_name":"Schafer Brother LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":9.68,"price_display":"9.68","price_state":"stated","total_value":164560.0,"total_display":"164,560.00","total_whole":"164,560","shares_owned_after":2753795.0,"shares_owned_after_display":"2,753,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-17","filed_date":"2009-02-19","scope":"insider"},{"id":5832615,"accession":"0000902664-09-000924","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-09-000924","line_url":"/filing/0000902664-09-000924#line-2","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; Schafer Brother LLC; SCHAFER OSCAR; OSS CAPITAL MANAGEMENT","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21561.0,"shares_display":"21,561","price_per_share":9.91,"price_display":"9.91","price_state":"stated","total_value":213669.51,"total_display":"213,669.51","total_whole":"213,670","shares_owned_after":2770795.0,"shares_owned_after_display":"2,770,795","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-13","filed_date":"2009-02-17","scope":"insider"},{"id":5832612,"accession":"0000902664-09-000924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-000924","line_url":"/filing/0000902664-09-000924#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; Schafer Brother LLC; SCHAFER OSCAR; OSS CAPITAL MANAGEMENT","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14140.0,"shares_display":"14,140","price_per_share":10.01,"price_display":"10.01","price_state":"stated","total_value":141541.4,"total_display":"141,541.40","total_whole":"141,541","shares_owned_after":2792356.0,"shares_owned_after_display":"2,792,356","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-12","filed_date":"2009-02-17","scope":"insider"},{"id":5583629,"accession":"0000902664-09-000284","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-09-000284","line_url":"/filing/0000902664-09-000284#line-2","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"OSS CAPITAL MANAGEMENT; Goffe Andrew J.; Schafer Brother LLC; SCHAFER OSCAR","owner_display_name":"OSS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":9.98,"price_display":"9.98","price_state":"stated","total_value":249500.0,"total_display":"249,500.00","total_whole":"249,500","shares_owned_after":2806496.0,"shares_owned_after_display":"2,806,496","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-30","filed_date":"2009-02-02","scope":"insider"},{"id":5583628,"accession":"0000902664-09-000284","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-000284","line_url":"/filing/0000902664-09-000284#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"OSS CAPITAL MANAGEMENT; Goffe Andrew J.; Schafer Brother LLC; SCHAFER OSCAR","owner_display_name":"OSS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":10.1,"price_display":"10.10","price_state":"stated","total_value":252500.0,"total_display":"252,500.00","total_whole":"252,500","shares_owned_after":2831496.0,"shares_owned_after_display":"2,831,496","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-29","filed_date":"2009-02-02","scope":"insider"},{"id":5629924,"accession":"0000902664-09-000233","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-09-000233","line_url":"/filing/0000902664-09-000233#line-2","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Schafer Brother LLC; Goffe Andrew J.","owner_display_name":"OSS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":10.55,"price_display":"10.55","price_state":"stated","total_value":527500.0,"total_display":"527,500.00","total_whole":"527,500","shares_owned_after":2856496.0,"shares_owned_after_display":"2,856,496","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-28","filed_date":"2009-01-29","scope":"insider"},{"id":5629923,"accession":"0000902664-09-000233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-000233","line_url":"/filing/0000902664-09-000233#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Schafer Brother LLC; Goffe Andrew J.","owner_display_name":"OSS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":10.32,"price_display":"10.32","price_state":"stated","total_value":516000.0,"total_display":"516,000.00","total_whole":"516,000","shares_owned_after":2906496.0,"shares_owned_after_display":"2,906,496","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-27","filed_date":"2009-01-29","scope":"insider"},{"id":6003305,"accession":"0000902664-09-000134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-000134","line_url":"/filing/0000902664-09-000134#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"SCHAFER OSCAR; OSS CAPITAL MANAGEMENT; Goffe Andrew J.; Schafer Brother LLC","owner_display_name":"SCHAFER OSCAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1100000.0,"total_display":"1,100,000.00","total_whole":"1,100,000","shares_owned_after":2956496.0,"shares_owned_after_display":"2,956,496","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-16","filed_date":"2009-01-21","scope":"insider"},{"id":5714182,"accession":"0000902664-09-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-000050","line_url":"/filing/0000902664-09-000050#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"SCHAFER OSCAR; Goffe Andrew J.; OSS CAPITAL MANAGEMENT; Schafer Brother LLC","owner_display_name":"SCHAFER OSCAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7989.0,"shares_display":"7,989","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":87879.0,"total_display":"87,879.00","total_whole":"87,879","shares_owned_after":3056496.0,"shares_owned_after_display":"3,056,496","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-09","filed_date":"2009-01-13","scope":"insider"},{"id":6033222,"accession":"0000902664-09-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-09-000039","line_url":"/filing/0000902664-09-000039#line-2","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; SCHAFER OSCAR; Schafer Brother LLC; OSS CAPITAL MANAGEMENT","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29039.0,"shares_display":"29,039","price_per_share":11.09,"price_display":"11.09","price_state":"stated","total_value":322042.51,"total_display":"322,042.51","total_whole":"322,043","shares_owned_after":3064485.0,"shares_owned_after_display":"3,064,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-08","filed_date":"2009-01-09","scope":"insider"},{"id":6033217,"accession":"0000902664-09-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-000039","line_url":"/filing/0000902664-09-000039#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; SCHAFER OSCAR; Schafer Brother LLC; OSS CAPITAL MANAGEMENT","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":11.16,"price_display":"11.16","price_state":"stated","total_value":558000.0,"total_display":"558,000.00","total_whole":"558,000","shares_owned_after":3093524.0,"shares_owned_after_display":"3,093,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-07","filed_date":"2009-01-09","scope":"insider"},{"id":5746724,"accession":"0000902664-09-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-09-000023","line_url":"/filing/0000902664-09-000023#line-2","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Schafer Brother LLC","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":11.05,"price_display":"11.05","price_state":"stated","total_value":552500.0,"total_display":"552,500.00","total_whole":"552,500","shares_owned_after":3143524.0,"shares_owned_after_display":"3,143,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-06","filed_date":"2009-01-07","scope":"insider"},{"id":5746722,"accession":"0000902664-09-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-000023","line_url":"/filing/0000902664-09-000023#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Schafer Brother LLC","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66290.0,"shares_display":"66,290","price_per_share":11.01,"price_display":"11.01","price_state":"stated","total_value":729852.9,"total_display":"729,852.90","total_whole":"729,853","shares_owned_after":3193524.0,"shares_owned_after_display":"3,193,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-05","filed_date":"2009-01-07","scope":"insider"},{"id":5733490,"accession":"0000902664-09-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-09-000011","line_url":"/filing/0000902664-09-000011#line-2","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Schafer Brother LLC; SCHAFER OSCAR; OSS CAPITAL MANAGEMENT; Goffe Andrew J.","owner_display_name":"Schafer Brother LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34621.0,"shares_display":"34,621","price_per_share":11.02,"price_display":"11.02","price_state":"stated","total_value":381523.42,"total_display":"381,523.42","total_whole":"381,523","shares_owned_after":3259814.0,"shares_owned_after_display":"3,259,814","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5733489,"accession":"0000902664-09-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-09-000011","line_url":"/filing/0000902664-09-000011#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Schafer Brother LLC; SCHAFER OSCAR; OSS CAPITAL MANAGEMENT; Goffe Andrew J.","owner_display_name":"Schafer Brother LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74409.0,"shares_display":"74,409","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":818499.0,"total_display":"818,499.00","total_whole":"818,499","shares_owned_after":3294435.0,"shares_owned_after_display":"3,294,435","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-31","filed_date":"2009-01-05","scope":"insider"},{"id":3842742,"accession":"0000902664-08-003494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-08-003494","line_url":"/filing/0000902664-08-003494#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NA","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Schafer Brother LLC","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67.0,"shares_display":"67","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":737.0,"total_display":"737.00","total_whole":"737","shares_owned_after":3368844.0,"shares_owned_after_display":"3,368,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-29","filed_date":"2008-12-31","scope":"insider"},{"id":2855335,"accession":"0000902664-08-003465","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-08-003465","line_url":"/filing/0000902664-08-003465#line-3","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOWN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; SCHAFER OSCAR; OSS CAPITAL MANAGEMENT; Schafer Brother LLC","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1255.0,"shares_display":"1,255","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":13805.0,"total_display":"13,805.00","total_whole":"13,805","shares_owned_after":3368911.0,"shares_owned_after_display":"3,368,911","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-26","filed_date":"2008-12-29","scope":"insider"},{"id":2855331,"accession":"0000902664-08-003465","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-08-003465","line_url":"/filing/0000902664-08-003465#line-2","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOWN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; SCHAFER OSCAR; OSS CAPITAL MANAGEMENT; Schafer Brother LLC","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9503.0,"shares_display":"9,503","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":104533.0,"total_display":"104,533.00","total_whole":"104,533","shares_owned_after":3370166.0,"shares_owned_after_display":"3,370,166","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-24","filed_date":"2008-12-29","scope":"insider"},{"id":2855327,"accession":"0000902664-08-003465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-08-003465","line_url":"/filing/0000902664-08-003465#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOWN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"Goffe Andrew J.; SCHAFER OSCAR; OSS CAPITAL MANAGEMENT; Schafer Brother LLC","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38735.0,"shares_display":"38,735","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":426085.0,"total_display":"426,085.00","total_whole":"426,085","shares_owned_after":3379669.0,"shares_owned_after_display":"3,379,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":3919535,"accession":"0000902664-08-003143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-08-003143","line_url":"/filing/0000902664-08-003143#line-1","is_derivative":false,"issuer_cik":"0001135943","issuer_name":"SMART BALANCE, INC.","issuer_ticker":"SMBL","issuer_name_source":null,"issuer_url":"/issuer/0001135943","owner_cik":null,"owner_name":"Goffe Andrew J.; OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Schafer Brother LLC","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230000.0,"shares_display":"230,000","price_per_share":7.06,"price_display":"7.06","price_state":"stated","total_value":1623800.0,"total_display":"1,623,800.00","total_whole":"1,623,800","shares_owned_after":6052270.0,"shares_owned_after_display":"6,052,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-06","filed_date":"2008-11-10","scope":"insider"},{"id":2548936,"accession":"0000902664-08-003101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-08-003101","line_url":"/filing/0000902664-08-003101#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Schafer Brother LLC; Goffe Andrew J.","owner_display_name":"OSS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6286.0,"shares_display":"6,286","price_per_share":10.65,"price_display":"10.65","price_state":"stated","total_value":66945.9,"total_display":"66,945.90","total_whole":"66,946","shares_owned_after":3418404.0,"shares_owned_after_display":"3,418,404","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-29","filed_date":"2008-10-31","scope":"insider"},{"id":2964070,"accession":"0000902664-08-002920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-08-002920","line_url":"/filing/0000902664-08-002920#line-1","is_derivative":false,"issuer_cik":"0001135943","issuer_name":"SMART BALANCE, INC.","issuer_ticker":"SMBL","issuer_name_source":null,"issuer_url":"/issuer/0001135943","owner_cik":null,"owner_name":"Goffe Andrew J.; OSS CAPITAL MANAGEMENT; SCHAFER OSCAR; Schafer Brother LLC","owner_display_name":"Goffe Andrew J.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":1198000.0,"total_display":"1,198,000.00","total_whole":"1,198,000","shares_owned_after":6282270.0,"shares_owned_after_display":"6,282,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-06","filed_date":"2008-10-08","scope":"insider"},{"id":4063610,"accession":"0000902664-08-001729","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-08-001729","line_url":"/filing/0000902664-08-001729#line-1","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":null,"owner_name":"OSS CAPITAL MANAGEMENT; Schafer Brother LLC; SCHAFER OSCAR; Goffe Andrew J.","owner_display_name":"OSS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":118000.0,"shares_display":"118,000","price_per_share":9.73,"price_display":"9.73","price_state":"stated","total_value":1148140.0,"total_display":"1,148,140.00","total_whole":"1,148,140","shares_owned_after":3424690.0,"shares_owned_after_display":"3,424,690","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-27","filed_date":"2008-03-31","scope":"insider"},{"id":3232844,"accession":"0000902664-08-001701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-08-001701","line_url":"/filing/0000902664-08-001701#line-1","is_derivative":false,"issuer_cik":"0001331301","issuer_name":"SMART BALANCE, INC.","issuer_ticker":"SMBL","issuer_name_source":null,"issuer_url":"/issuer/0001331301","owner_cik":"0001430370","owner_name":"Goffe Andrew J.","owner_display_name":"Goffe Andrew J.","owner_url":"/insider/0001430370","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock ($.0001 par value)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":341500.0,"shares_display":"341,500","price_per_share":5.77,"price_display":"5.77","price_state":"stated","total_value":1970455.0,"total_display":"1,970,455.00","total_whole":"1,970,455","shares_owned_after":6482270.0,"shares_owned_after_display":"6,482,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-14","filed_date":"2008-03-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000815838","name":"NOVEN PHARMACEUTICALS INC","url":"/issuer/0000815838","role":"Ten percent owner","n_filings":17,"first_seen":"2008-03-31","last_seen":"2009-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001331301","name":"SMART BALANCE, INC.","url":"/issuer/0001331301","role":"Ten percent owner","n_filings":3,"first_seen":"2008-03-28","last_seen":"2008-11-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001430370","retrieved_at":"2026-08-23T22:14:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}